Literature DB >> 34950885

Activation of a diluted E. coli cell-free transcription-translation system within liposomes by hypertonic concentration.

Yukino Matsui1, Toshiki Akui1, Nobuhide Doi1, Kei Fujiwara1.   

Abstract

We present a protocol for activating protein synthesis in liposomes encapsulating a diluted E. coli cell extract-based TX-TL (transcription-translation) system by hypertonic concentration. Protein expression is turned on in the liposome-encapsulated TX-TL system by simple treatment with a concentrated external solution. The expression of sfGFP is demonstrated here, but it can be applied to other proteins. This protocol can be applied to the development of artificial cells utilizing the switch-on mechanism to activate protein expression, responding to the outer environment. For complete details on the use and execution of this protocol, please refer to Akui et al. (2021).
© 2021 The Author(s).

Entities:  

Keywords:  Biophysics; Biotechnology and bioengineering; Molecular Biology; Protein Biochemistry

Mesh:

Substances:

Year:  2021        PMID: 34950885      PMCID: PMC8672043          DOI: 10.1016/j.xpro.2021.101003

Source DB:  PubMed          Journal:  STAR Protoc        ISSN: 2666-1667


Before you begin

Prepare S30 cell extract for cell-free TX-TL system

The TX-TL system required for this protocol can either be prepared from an E. coli cell-extract (Fujiwara and Doi, 2016) or reconstituted from individual components (PURE system, Shimizu et al., 2001). This section describes detailed steps for preparing an E coli cell extract-based TX-TL system.

Day 1

Prepare and autoclave the buffers and media as described below. 1 L of 2× YTPG media [Yeast Extract 10 g, Tryptone 16 g, NaCl 5 g, K2HPO4 7 g, KH2PO4 3 g, 15 mL of 1 M KOH to adjust pH7.2, and then, filled up with distilled water to 950 mL]. After autoclave, add 50 mL of 2 M filter-sterilized glucose. Glucose should be added to the media after autoclave. We typically use 2 L baffled culture flasks with foil for cell culture. It is no problem to use different sizes of baffled flasks or Sakaguchi flasks. S30A Buffer [10 mM BisTris, 60 mM GluK (potassium-glutamate), 10 mM Mg(oAc)2] Prepare 10 mL per 1 L culture. S30B Buffer [10 mM BisTris, 60 mM GluK, 14 mM Mg(oAc)2] The amount needed varies according to the buffer exchange protocol. In the case of the Amicon filter method, prepare 100 mL per 1 L culture. In the case of dialysis protocol, prepare 1 L or more (it depends on the volume of cell extract). 400 mM Sucrose Prepare 200 mL per 1 L culture. Store in the refrigerator and cool it on ice prior to use. Cell Culture Inoculate Escherichia coli BL21(DE3) in 10 mL of 2× YTPG or LB. This protocol is not suitable for some Escherichia coli strains. It may be possible to obtain cell extract from other E. coli strains. For example, we confirmed that it was possible with MG1655 and BL21-CodonPlus(DE3) strains. However, some strains, such as BL21 Star (DE3) (it has a mutation in RNaseE gene) are not suitable. In most cases, we recommend using BL21(DE3) or BL21-CodonPlus(DE3) strains. Cultivate the cells for overnight (16–20 h) at 37°C with shaking (120–200 rpm).

Day 2

Cell Culture, Harvest Inoculate 1 L of 2×YTPG media with 10 mL of the o/n culture. Grow the culture at 37°C with shaking at 170 rpm until OD600 reaches 1.5–1.8, which requires 2–3 h cultivation. When your template for TX-TL uses T7 promoter for gene expression, express T7 RNA polymerase encoded in DE3 gene by adding IPTG (0.1 mM final) at OD600 = 0.1. CRITICAL: Collect cells at late log phase. OD600 should be measured after dilution of the cell culture with water or medium to ensure linear correlation between OD600 and cell number. Before harvesting, leave the culture for 15 min at room temperature (20°C–30°C). During the process, pre-cool the centrifuge and rotor for cell collection. Collect cells by centrifugation. For example, 15,000 × g centrifugation for 5 min at 4°C. Centrifugation speed is not critical. Remove the supernatant and keep the cell pellet on ice. CRITICAL: Keep the sample on ice all the time after this step. Lysozyme treatment Wash a paint brush with 5–10 mL of 400 mM sucrose in a 50 mL tube (Figure 1).
Figure 1

A paint brush washed with the sucrose solution.

Add 20 mL of 400 mM ice-cold sucrose to the cell pellet and resuspend softly using the brush. If you have more than one pellet, you can pour this cell suspension into the other pellet to gather cells in a single tube (Methods video S1). Resuspend all the cell pellets as homogenous as possible. After resuspending, pour the total cell suspension to a single 50 mL tube and centrifuge at 15,000 × g for 2 min at 4°C. Remove the supernatant and resuspend the cell pellet with 20 mL sucrose using the brush. Centrifuge again. Remove the supernatant and resuspend the cell pellet in 30 mL sucrose. Add 150 μL of 20 mg/mL Lysozyme to the cell suspension and mix the cell suspension with moderate shakes until the lysozyme solution is homogeneously diffused. Repeat this step 3 times (in total you will add 600 μL lysozyme solution). Keep the sample on ice for 1 h (lysozyme treatment). Centrifuge at 15,000 × g for 2 min at 4°C. Wash the cell pellet twice by repetitively resuspending in 30 mL sucrose and centrifuging to remove the supernatant. After the final centrifugation step, remove the supernatant and measure the wet cell weight (typically 2 g/1 L culture). Freeze and thaw Resuspend the cell pellet with the cold S30A Buffer (1.5 mL per gram wet cell pellet weight). Aliquot the cell suspension into 1.7 mL tubes (0.5–1 mL for each tube). Dip the tubes into liquid nitrogen for 5 min. Transfer the tubes to ice water until fully thawed (Use a floating tube rack and take care not to immerse the lid of the tube in ice water). To facilitate thawing, any ice that has formed around the tubes should be removed at about 3, 6, 9 min after the transfer. This step would take around 30 min. Centrifuge for 1 h at 30,000 × g at 4°C. Run-off reaction Dispense the supernatant into 1.7 mL tubes (1 mL for each tube). Incubate the tubes for 1 h at 37°C with shaking at 200 rpm. The supernatant should become milky white during this step. Pre-warm centrifuge to 37°C for the next step (7c). Centrifuge at 10,000 × g for 20 min at 4°C. Collect the supernatants in a single 15 mL tube or multiple 1.7 mL tubes (The merit of collection in multiple 1.7 mL tubes is faster thawing in step 8a). Store the collected supernatants as S30 cell extract at −20°C or below (this step can be skipped if the next step is going to be performed on the same day). Flash-freezing is not required.

Day 3

Buffer exchange Leave the S30 extract on ice until completely thawed if frozen. Exchange the buffer with S30B buffer by dialysis (Usage of pore membrane smaller than 14 kDa MWCO and two-rounds dialysis is recommended) or Amicon Ultra centrifugal filter (10 kDa MWCO). In the case of Amicon filter, concentrate and dilute with the S30B Buffer, and repeat this cycle until the S30A Buffer is diluted 500 to 1000 times with the S30B buffer. Using the Amicon filter, concentrate the S30 extract until it reaches less than half the volume of the original S30 extract in step a Measure the concentration of the S30 cell extract using a BCA assay kit. Dispense 10–100 μL of S30 extract into tubes and store them at −20°C or less. Typically, about 30 mg cell extract is obtained from 1 g wet cells weight. Flash-freezing is not required. But aliquot S30 extract for storage to avoid multiple freeze-thaw cycles. (Although we have not tested how many freeze-thaw cycles could significantly decrease the TX-TL activity, we find that the activity is not affected by up to 2 freeze-thaw cycles.) A paint brush washed with the sucrose solution.

Prepare an indicator for observation of liposomes

We recommend using a fluorescent indicator to aid identification of liposomes in the microscopic field; without a fluorescent indicator it is not easy to judge whether spherical objects observed in transmitted light are liposomes or not (since contaminant oil in water emulsion is also spherical). In this section, we outline the steps for the preparation of mCherry. mCherry can be replaced with other fluorescent molecules if desired. Transform E. coli BL21 (DE3) with pET29-mCherry-His (Akui et al., 2021) using competent cells, and cultivate overnight (16–20 h) at 37°C on LB agar medium supplemented with 50 μg/mL kanamycin at final. In the evening, inoculate the transformant into 1 mL LB medium supplemented with 50 μg/mL kanamycin and cultivate the cells overnight (16–20 h) at 37°C with shaking at 120–200 rpm. Inoculate 1 L of LB medium containing 50 μg/mL kanamycin with 1 mL of the precultured cells. Cultivate the cells at 37°C with shaking 120–200 rpm to reach OD600 = 0.1–0.4. Add 0.1 mM IPTG and cultivate overnight (16–20 h) at 18°C with shaking at 120–200 rpm.

Day 4

In the morning, collect the cells and resuspend the cell pellet in 10 mL of Binding Buffer [50 mM Tris-HCl (pH 8.0), 500 mM NaCl, 40 mM Imidazole]. Disrupt the cells by sonication. During sonication, the tubes should be cooled with ice water. Collect the supernatant after 15,000 × g centrifuge for 10 min at 4°C. Purify the mCherry from the supernatant by using HisTrap column (or equivalent) following the manufacturer’s instructions. For wash and elution, the Binding Buffer and Elution Buffer [50 mM Tris-HCl (pH 8.0), 500 mM NaCl, and 400 mM Imidazole] are used, respectively. Exchange the buffer with 20 mM Hepes-KOH (pH 7.6) by dialysis or the Amicon Filter method. Because 16 μM mCherry is required for the preparation of the TX-TL system solution below, concentrate mCherry by the Amicon Filter if its concentration is lower than 16 μM. CRITICAL: It is important to reduce the osmotic pressure derived from the buffer for the hypertonic concentration for protein expression. NaCl and Imidazole concentration derived from mCherry purification should be less than 1 mM in the final solution for the TX-TL system. We do not recommend the addition of glycerol to the purification buffers. Dispense 10–100 μL of the mCherry solution into tubes and store at −20°C or below. Flash-freezing is not required.

Key resources table

All reagents and supplies can be replaced with alternatives.

Materials and equipment

Mineral oil

Just after opening the mineral oil tube, we always treat the oil with a molecular sieve to remove water and other small chemicals which can be contaminated from environments. Add 10 g of molecular sieve 4A to 100 mL mineral oil. [Store at room temperature (20°C–30°C)]. 2× YTPG medium Glucose should be added after autoclaving the medium that contains all the rest. S30A Buffer Autoclave before use. A month’s storage at 4°C is assured. S30B Buffer Autoclave before use. A month’s storage at 4°C is assured. Binding Buffer Autoclave before use. Two years storage at 4°C is assured. Elution Buffer Autoclave before use. Two years storage at 4°C is assured. 50× NTP mixture Store at −20°C or below. Two years storage is assured. 1× NTP indicates a mixture of 2.0 mM ATP, 2.0 mM GTP, 1.3 mM UTP, and 1.3 mM CTP. 5× reaction mixture Store at -20°C or below. Two years storage is assured. 1 μL of 5× reaction mixture is used to prepare a 5 μL TX-TL system. Scale up or down the total stock amount for your purpose. 1× reaction mixture indicates a mixture of 50 mM Hepes-KOH (pH7.6), 100 mM GluK, 198 μg/mL tRNA mixture, 0.068 mM FD, 80 mM Creatine phosphate, 0.6 mM 20 amino acids mixture, 1 mM Spermidine, 1× NTP mixture, and 1 mM IPTG. 20 amino acids mixture is prepared by dissolving 20 amino acids in Ultrapure water. TX-TL system solution Prepare before use. In this protocol, the final concentration of magnesium in the TX-TL system is set as 15 mM in total. Because S30 cell extract contains 14 mM magnesium, 3.5 mM magnesium in the TX-TL system is derived from the S30 cell extract. GluMg added is to compensate for the rest. 5× reaction mixture, Cell extract, GluMg and Creatine kinase can be replaced with PURE system. External buffer Store at −20°C or below. Two years storage is assured. CRITICAL: The osmotic pressure of the External buffer should be the same as TX-TL system solution. S30B Buffer is added to compensate for the small molecules that cell extract contains in the TX-TL system solution. Hepes-KOH (pH 7.6) is the replacement for mCherry. 20 μL of the External buffer is used to prepare one liposome sample. Scale up or down the total stock amount for your purpose. 2× External buffer Store at −20°C or below. Two years storage is assured. 20 μL of 2× External buffer is used for one hypertonic treatment. Scale up or down the total stock amount for your purpose.

Silicon spacer

To make the silicon spacer for microscopic observation, cut a silicone rubber sheet (0.5 or 1 mm thick) into 1 cm squares and make a hole in it by using a hole punch.

Step-by-step method details

Preparation of liposomes encapsulating a diluted E. coli TX-TL system

Timing: 90 min In this step, liposomes are prepared by a modified droplet-transfer method (Fujiwara and Yanagisawa, 2014) Preparation of lipid solution Dry 40 μL of 25 mg/mL POPC (dissolved in chloroform and stored at −20°C in a round glass microtube) under Ar or N2 gas flow. We typically perform this process without using a vacuum desiccator. Add 500 μL mineral oil to the dried POPC. Incubate the lipid solution at 80°C for 1 h (e.g., in an Aluminum block incubator). Do not cap the tube in this process. Cool the tube to room temperature (20°C–30°C). After capping the tube by an attached screw cap, vortex the lipid solution for 1 min. The lipid solution can be stored at room temperature (20°C–30°C) for at least more than several hours with the tube wrapped by aluminum foil. Vortex again before the emulsification (step 2). Emulsification Prepare the TX-TL system solution on ice. Add 20 μL of ultrapure water to 5 μL of the TX-TL system to generate a 1/5-fold dilution. Add 50 μL of the lipid solution into a 0.6 mL tube and pipette 1 μL of the diluted TX-TL system to the lipid solution. From this step, prepare samples at room temperature (20°C–30°C) . Tap the tube about 10 times for emulsification. The size range of liposomes depends on how strong and how many times you tap the tube in this step. We recommend preparing liposomes larger than 5 μm (diameter) for microscopic observation. You may need to optimize this step in order to get an appropriate size range. Keep the emulsified solution at room temperature (20°C–30°C) until used in step 3d. Tapping the tube might be required to form emulsions again just before step 3d. Preparation of liposomes Prepare the External buffer. Add 80 μL of ultrapure water to 20 μL of the External buffer in a 1.7 mL tube to generate a 1/5-fold dilution (in order to balance the osmotic pressure between the inside and outside of the liposomes). Carefully add 50 μL of the lipid solution (prepared in step 1) on top of the diluted External buffer with pipette (Figure 2).
Figure 2

Pipetting emulsion onto the oil phase

(A) Lipids in oil is added on top of the diluted External buffer.

(B) Emulsion is pipetted onto the oil phase.

(C) A resultant solution with phases. The solution is centrifuged to form liposomes at the next step.

Add 50 μL of the emulsified solution (prepared in step 2) onto the oil phase with the lipids (Figure 2). CRITICAL: Be careful not to mix the emulsified solution with the phase of diluted External buffer (water phase). Centrifuge at 20,000 × g for 5 min at 4°C and remove the oil phase. Remove as much of the oil phase as possible. Contaminant oil forms a liposome-like sphere structure in the solution (oil in water emulsion). Recover liposomes by gently pipetting the bottom of the tube and transfer the liposome solution into a new 0.6 mL tube. Pipetting emulsion onto the oil phase (A) Lipids in oil is added on top of the diluted External buffer. (B) Emulsion is pipetted onto the oil phase. (C) A resultant solution with phases. The solution is centrifuged to form liposomes at the next step.

Activation of the TX-TL system inside liposomes by hypertonic treatment

Timing: 1–16 h. (Depending on reaction time.) In this step, the prepared liposomes are treated by osmolytes to concentrate molecules within liposomes, and the activation of the TX-TL system is confirmed by measuring sfGFP fluorescence. A fluorescent microscope is used to obtain the fluorescent images. We use sfGFP expression as a demonstration of this protocol. Other genes should be expressed by the protocol. We have confirmed the expression of α-hemolysin by the protocol (Akui et al., 2021). For the experimental condition, mix 20 μL of 2× External buffer with 20 μL of liposome solution in a 1.7 mL tube by gently pipetting. As a negative control (without hypertonic treatment), mix 20 μL 1/5-diluted External buffer with 20 μL of liposome solution in another 1.7 mL tube by gently pipetting. Incubate the sample at 25°C for an appropriate time (1–16 h). The activation of the TX-TL system starts as soon as you add a 2× External buffer to the liposome solution. It may take 30 min to an hour for the sfGFP to be expressed to a detectable level. (In the case that T7 promoter is used for DNA template, the speed of protein synthesis and the final amount will be higher than when the endogenous promoter is used.) Pipette the reacted sample (hypertonic treatment) into the central chamber made of silicon spacer on a slide glass (Figure 3). Do the same for the negative control on a separate glass slide.
Figure 3

A unit spaced with silicon spacer for microscopic observation of liposomes

(A) A silicon spacer spotted on the cover glass.

(B) Spotting liposome solution.

(C) The silicon spacer chamber covered with another cover glass.

A unit spaced with silicon spacer for microscopic observation of liposomes (A) A silicon spacer spotted on the cover glass. (B) Spotting liposome solution. (C) The silicon spacer chamber covered with another cover glass. To prevent the reacted sample from drying, cover the sample with another slide glass (Figure 3), especially if the pipetted sample volume is a few microliters or the observation takes a long time. Observe the fluorescence of mCherry (indicator) and sfGFP (synthesized protein), respectively, by fluorescent microscope.

Expected outcomes

Tens to hundreds of liposomes are collected by the protocol, and at least 72% liposomes show synthesis of sfGFP in cytosols (see also Akui et al, 2021). Typical data obtained by the protocol is shown in Figure 4.
Figure 4

A representative result obtained by this protocol (16 h incubation)

The thresholds of Indicator (mCherry) images are differently adjusted among the two conditions to clearly show the position of liposomes in both cases. Thus, the fluorescent levels of indicator (mCherry) do not correlate with the actual mCherry concentrations: mCherry is concentrated by the hypertonic treatment.

A representative result obtained by this protocol (16 h incubation) The thresholds of Indicator (mCherry) images are differently adjusted among the two conditions to clearly show the position of liposomes in both cases. Thus, the fluorescent levels of indicator (mCherry) do not correlate with the actual mCherry concentrations: mCherry is concentrated by the hypertonic treatment.

Limitations

The TX-TL activity inside liposomes can’t be switched on by more than 5-fold hypertonic treatment, although it was confirmed that macromolecules inside liposomes can be concentrated up to 30 times by hypertonic treatment (Akui et al, 2021). (The osmotic pressure ratio of the outer solution to the inner solution of liposomes determines the concentration factor by hypertonic treatment. if the ratio is 5, the concentration of macromolecules inside liposomes become 5-times higher by the treatment.)

Troubleshooting

Problem 1

No or low TX-TL activity of prepared S30 cell extract. (Before you begin, prepare S30 cell extract for cell-free TX-TL system)

Potential solution

(i) Check the timing of the cell collection in step 3b. The activity of the TX-TL system will significantly decrease if stationary phase cells were collected. Optimal OD600 for cultivation may depend on the apparatus to measure OD600. Typically, less than half of the maximal OD600 is the best OD600 for collecting cells. (ii) Cell lysis and the centrifugation to collect the extract after cell lysis can be a critical step for activity. It takes at least 30 min to collect sufficient volume of the supernatant (0.3–0.7 mL per 1 mL cell suspension) by centrifugation in step 6. If cell debris were completely pelleted within a few min centrifugation, either the cell disruption failed (In this case, cell extract seems to be clear) or the timing of cell harvest was too late (In this case, cell extract shows yellow color). A small volume of supernatant (less than 0.3 mL per 1 mL cell suspension) suggests extensive cell lysis. In this case, the timing of cell harvest was too early, or lysozyme treatment was too strong. In the latter case, decrease amounts of lysozyme or shorten the reaction time. (iii) Otherwise, try other preparation methods, which use French press, sonication, or other apparatus for cell disruption. (iv) Cell extract can be replaced with a reconstituted transcription-translation system (PURE system) in the original study (Akui et al, 2021).

Problem 2

Poor emulsification. (Step-by-step method details, preparation of liposomes encapsulating a diluted E. coli TX-TL system, step 2 Emulsification). Poor emulsification will lead to poor liposome formation. In some cases, emulsion disappears after several minutes, with water and oil phases separating. (i) Minimize the time between emulsification and liposome preparation (i.e., these two steps should be performed within about 5 min of each other). Tap the tube and form emulsions again just before adding to the next step. If the time is not the cause, it is mainly attributed to the condition of lipids solution. Primarily, (ii) Vortex the lipid solution (prepared in step-by-step method details, 1. Preparation of lipid solution) just before pipetting the diluted TX-TL system for emulsification. (iii) Try an alternative method for preparing lipids solution, such as sonication in a hot water bath (Kohyama et al., 2019, (Kohyama et al., 2020)). Finally, (iv) Water contamination in lipids should be concerned: Any water contamination should be evaporated in a vacuum desiccator for several hours after drying chloroform.

Problem 3

Poor liposome yield. (Step-by-step method details, preparation of liposomes encapsulating a diluted E. coli TX-TL system, step 3 Preparation of liposomes) Primarily, check if emulsions are successfully prepared by using a microscope. (step 2 Emulsification). If emulsions are not formed, refer to Problem 2 & Potential solution. If emulsions are successfully formed, (i) check if the osmotic pressure between the inner solution (TX-TL system) and the outer solution (External Buffer) are balanced in step 3 Preparation of liposomes. Refer to the CRITICAL in materials and equipment, External buffer. (ii) Alternative solutions may be found in the condition of lipid solution. Use the lipid solution prepared on the same day. If liquid paraffin is used instead of mineral oil in step 1 Preparation of lipid solutions, we recommend to use liquid paraffin that is just after opened or stored in the freezer after it was opened.

Problem 4

No liposome was found in the microscopic field. (Step-by-step method details, activation of the TX-TL system inside liposomes by hypertonic treatment, step 7) (i) Increase the concentration of fluorescent proteins or molecules, the indicator of liposome position: mCherry in this protocol. (ii) Refer to Problem 3 & Potential solution.

Problem 5

Protein expression could not be detected in liposomes after hypertonic treatment (e.g., the fluorescence intensity of GPF in the experimental condition was not significantly stronger than that in the negative control). (Step-by-step method details, activation of the TX-TL system inside liposomes by hypertonic treatment, step 7) Primarily, check if the TX-TL system solution has the activity in a test tube. If TX-TL works in the case of the tube reaction, lipid membrane or semipermeability is the cause of the low TX-TL activity inside liposomes. If polar lipids or other anionic lipids are used, negative charges of lipids affect TX-TL activity. In this case, add 10 mg/mL or more BSA to the TX-TL system like in our previous study (Yoshida et al., 2019). If lipids with neutral charges are used, but the TX-TL activity is low, some essential small molecules for TX-TL may leak out from liposomes due to the semi-permeability of lipid membranes or the hypertonic treatment. In this case, please make sure that the External buffer contains the essential small molecules for TX-TL reaction.

Resource availability

Lead contact

[Kei Fujiwara] (fujiwara@bio.keio.ac.jp).

Materials availability

Plasmids constructed in this study are available from the corresponding author on request.
REAGENT or RESOURCESOURCEIDENTIFIER
Bacterial and virus strains

Escherichia coli BL21 (DE3)New England BioLabsCat# C2527

Chemicals, peptides, and recombinant proteins

Folinic acidTokyo Chemical IndustryCat# C2235
Ultrapure waterThermo Fisher ScientificCat# 10977023
Potassium glutamateSigma-AldrichCat# G1501-1KG
Magnesium glutamateSigma-AldrichCat# 49605-250G
Magnesium acetateNacalai TesqueCat# 208-21
tRNARocheCat# 10109541001
Creatine kinaseRocheCat# 10127566001
ATPWako ChemicalsCat# 014-16913
GTPWako ChemicalsCat# 073-03113
CTPTokyo Chemical IndustryDiscontinued
UTPAffymetrixDiscontinued
IPTGNacalai TesqueCat# 19742-94
Tris(hydroxymethyl)aminomethaneNacalai TesqueCat# 35434-05
NaClNacalai TesqueCat# 31320-05
ImidazoleNacalai TesqueCat# 19004-35
HEPESNacalai TesqueCat# 17546-05
HClNacalai TesqueCat# 18321-05
KOHNacalai TesqueCat# 28616-45
SucroseNacalai TesqueCat# 30404-45
AlaNacalai TesqueCat# 01115-22
CysNacalai TesqueCat# 10309-12
AspNacalai TesqueCat# 03561-12
GluNacalai TesqueCat# 16911-22
PheNacalai TesqueCat# 26910-22
GlyNacalai TesqueCat# 17109-35
HisNacalai TesqueCat# 18116-92
IleNacalai TesqueCat# 20330-02
LysTokyo Chemical IndustryCat# L0129
LeuNacalai TesqueCat# 20327-62
MetNacalai TesqueCat# 21719-02
AsnNacalai TesqueCat# 03427-82
ProNacalai TesqueCat# 29001-42
GlnNacalai TesqueCat# 16919-42
ArgNacalai TesqueCat# 03321-65
SerNacalai TesqueCat# 30608-72
ThrNacalai TesqueCat# 33820-82
ValNacalai TesqueCat# 36108-42
TrpWako ChemicalsCat# 202-03383
TyrNacalai TesqueCat# 35709-02
SpermidineNacalai TesqueCat# 32108-91
Creatine phosphateWako ChemicalsCat# 030-04584
ChloroformNacalai TesqueCat# 08402-55
1-Palmitoyl-2-Oleoylphosphatidylcholine (POPC)Avanti Polar LipidsCat# 850457C
LysozymeNacalai TesqueCat# 19499-04
AmpicillinNacalai TesqueCat# 02739-32
KanamycinNacalai TesqueCat# 19860-44
Yeast ExtractGibcoCat# 212750
TryptoneNacalai TesqueCat# 35640-95
NaClNacalai TesqueCat# 31319-45
K2HPO4Nacalai TesqueCat# 28727-95
KH2PO4Nacalai TesqueCat# 28721-55
Mineral oilNacalai TesqueCat# 23306-84
GlucoseNacalai TesqueCat# 16805-35
Critical commercial assays

HisTrap HPGE HealthcareCat# 17524701
Amicon-Ultra 15 filter 10kMerck MilliporeCat# UFC901096
BCA Assay kitThermo Fisher ScientificCat# 23225

Recombinant DNA

pET29-mCherry-HisAkui et al. (2021)N/A
pOR2OR1-sfGFPFujiwara and Doi (2016)N/A

Others

molecular sieve 4ANacalai TesqueCat# 04171-05
Silicone rubber sheetTOGAWA Rubber Co. Ltd.Cat# K-125(50)

2× YTPG medium

ReagentAmount
Yeast Extract10 g
Tryptone16 g
NaCl5 g
K2HPO47 g
KH2PO43 g
KOH (1M)15 mL
Glucose (2M)50 mL
Distilled water935 mL
Total1 L

S30A Buffer

ReagentInitial concentration (mM)Final concentration (mM)Volume (mL)
Hepes-KOH pH7.62000100.05
GluK4000600.15
Mg(oAc)21000100.14
Ultrapure Watern/a9.66
Totaln/a10

S30B Buffer

ReagentInitial concentration (mM)Final concentration (mM)Volume (mL)
Hepes-KOH pH7.62000100.5
GluK4000601.5
Mg(oAc)21000141.4
Ultrapure Watern/a96.6
Totaln/a100

Binding Buffer

ReagentInitial concentration (mM)Final concentration (mM)Volume (mL)
Tris-HCl (pH8.0)10005010
NaCl1000500100
Imidazole1000408
Ultrapure Watern/an/a82
Totaln/an/a200

Elution Buffer

ReagentInitial concentration (mM)Final concentration (mM)Volume (mL)
Tris-HCl (pH8.0)10005010
NaCl1000500100
Imidazole100040080
Ultrapure Watern/an/a10
Totaln/an/a200

50× NTP mixture

ReagentInitial concentration (mM)50× Final concentration (mM)Volume (μL)
ATP50010020
GTP50010020
CTP5006513
UTP5006513
Ultrapure watern/an/a34
Totaln/an/a100

Store at −20°C or below. Two years storage is assured.

5× reaction mixture

ReagentInitial concentration5× Final concentrationVolume (μL)
Hepes-KOH pH7.62000 mM250 mM12.5
GluK4000 mM500 mM12.5
tRNA mixture51840 μg/mL990 μg/mL1.9
FD (folinic acid)33.9 mM0.34 mM1
Creatine phosphate1000 mM400 mM40
20 amino acids mixture20 mM each3 mM each15
Spermidine500 mM5 mM1
50× NTP mixture50×10
IPTG1000 mM5 mM0.5
Ultrapure watern/an/a5.6
Totaln/an/a100

Store at -20°C or below. Two years storage is assured.

TX-TL system solution

ReagentInitial concentrationFinal concentrationVolume (μL)
5× reaction mixture1
Cell extract40 mg/mL10 mg/mL1.25
GluMg200 mM11.5 mM0.3
mCherry16 μM4 μM1.25
Creatine kinase3000 μg/mL300 μg/mL0.5
DNA (pOR2OR1-sfGFP)200 nM20 nM0.5
Ultrapure watern/an/a0.2
Totaln/an/a5 μL

Prepare before use.

External buffer

ReagentInitial concentrationFinal concentrationVolume (μL)
5× reaction mixture1 x20
S30B Buffer0.25×25
GluMg200 mM11.5 mM5.8
Hepes-KOH (pH 7.6)20 mM5 mM25
Ultrapure watern/an/a24.3
Totaln/an/a100

Store at −20°C or below. Two years storage is assured.

2× External buffer

ReagentInitial concentrationFinal concentrationVolume (μL)
5× reaction mixture40
S30B Buffer0.5×50
GluMg1000 mM23 mM2.3
Hepes-KOH (pH 7.6)200 mM10 mM5
Ultrapure watern/an/a2.7
Totaln/an/a100

Store at −20°C or below. Two years storage is assured.

  7 in total

1.  Cell-free translation reconstituted with purified components.

Authors:  Y Shimizu; A Inoue; Y Tomari; T Suzuki; T Yokogawa; K Nishikawa; T Ueda
Journal:  Nat Biotechnol       Date:  2001-08       Impact factor: 54.908

2.  Conformational equilibrium of MinE regulates the allowable concentration ranges of a protein wave for cell division.

Authors:  Shunshi Kohyama; Kei Fujiwara; Natsuhiko Yoshinaga; Nobuhide Doi
Journal:  Nanoscale       Date:  2020-06-11       Impact factor: 7.790

3.  Cell-sized confinement controls generation and stability of a protein wave for spatiotemporal regulation in cells.

Authors:  Shunshi Kohyama; Natsuhiko Yoshinaga; Miho Yanagisawa; Kei Fujiwara; Nobuhide Doi
Journal:  Elife       Date:  2019-07-30       Impact factor: 8.140

4.  Generation of giant unilamellar liposomes containing biomacromolecules at physiological intracellular concentrations using hypertonic conditions.

Authors:  Kei Fujiwara; Miho Yanagisawa
Journal:  ACS Synth Biol       Date:  2014-02-10       Impact factor: 5.110

5.  Biochemical Preparation of Cell Extract for Cell-Free Protein Synthesis without Physical Disruption.

Authors:  Kei Fujiwara; Nobuhide Doi
Journal:  PLoS One       Date:  2016-04-29       Impact factor: 3.240

6.  Regulation of spatiotemporal patterning in artificial cells by a defined protein expression system.

Authors:  Aoi Yoshida; Shunshi Kohyama; Kei Fujiwara; Saki Nishikawa; Nobuhide Doi
Journal:  Chem Sci       Date:  2019-10-16       Impact factor: 9.825

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.